August 22, 2017 / 7:07 AM / 4 months ago

BRIEF-Medipost receives patent

Aug 22 (Reuters) - Medipost Co Ltd :

* Says it receives patent about TSP-1, TSP-2, IL-17BR and hb-egf associated with stem cell activities and applications thereof

* Says patent number is 2013094776

Source text in Korean: goo.gl/hbA3oo

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below